IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics
02 Sep 2015
DANBURY, CT, December 16, 2014 – IMS Health (NYSE:IMS) today announced that Mason Tenaglia has been appointed vice president, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics, a new position. In this role, Tenaglia is responsible for advancing the IMS Institute’s payer and managed care thought leadership, as well as engaging with key leaders in the healthcare industry, academia and government.
“I am extremely pleased that Mason, a recognized thought leader in managed care and payer reimbursement solutions, has joined us as a senior member of the Institute,” said Murray Aitken, IMS Health senior vice president and executive director of the IMS Institute for Healthcare Informatics. “The Institute advances global healthcare by providing current, unbiased information to the healthcare industry, academia, and government. Mason’s expertise in payment models is a great addition to the Institute team.”
Said Tenaglia, “I welcome the opportunity to advance the excellent work of the IMS Institute. Pharmaceutical reimbursement and novel payment models are critically important issues across all healthcare segments. Through the innovative use of information, insight and analysis, the Institute has become a respected and integral part of the global healthcare discussion. I look forward to contributing and enhancing the depth, scope and reach of the Institute as we continue to make a positive impact in healthcare worldwide.”
Tenaglia is a leading authority on understanding the impact of the Affordable Care Act on the healthcare industry, and is a frequent author and speaker on the topic. He is a member of the Pharmaceutical Executive Editorial Advisory Board, and serves as its advisor for Managed Care. Tenaglia began his consulting career at McKinsey & Company. He holds a BS degree in International Economics from the Walsh School of Foreign Service at Georgetown University, and an MBA in Finance and International Business from the University of Chicago.
About IMS Health
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. By applying sophisticated analytics and proprietary application suites hosted on the IMS One intelligent cloud, the company connects more than 10 petabytes of complex healthcare data on diseases, treatments, costs and outcomes to help its clients run their operations more efficiently. Drawing on information from 100,000 suppliers, and on insights from more than 45 billion healthcare transactions processed annually, IMS Health’s approximately 10,000 employees drive results for healthcare clients globally. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.
About the IMS Institute for Healthcare Informatics
The IMS Institute for Healthcare Informatics provides key policy setters and decision makers in the global health sector with unique and transformational insights into healthcare dynamics derived from granular analysis of information. It is a research-driven entity with a worldwide reach that collaborates with external healthcare experts from across academia and the public and private sectors to objectively apply IMS Health’s proprietary global information and analytical assets. More information about the IMS Institute can be found at: http://www.theimsinstitute.org.